Global Info Research released “Global Prenatal Second-Generation DNA Sequencing Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031”. This report includes an overview of the development of the Prenatal Second-Generation DNA Sequencing industry chain, the market status of Prenatal Second-Generation DNA Sequencing Market, and key Players in developed and Prenatal Second-Generation DNA Sequencing market, and analyze the cutting-edge technology, patent, hot applications and market trends of Prenatal Second-Generation DNA Sequencing industry.
According to our (Global Info Research) latest study, the global Prenatal Second-Generation DNA Sequencing market size was valued at US$ 1327 million in 2024 and is forecast to a readjusted size of USD 2498 million by 2031 with a CAGR of 9.4% during review period.
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Prenatal Second-Generation DNA Sequencing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prenatal Second-Generation DNA Sequencing, with revenue, gross margin and global market share of Prenatal Second-Generation DNA Sequencing from 2020 to 2025.
Chapter 3, the Prenatal Second-Generation DNA Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the Prenatal Second-Generation DNA Sequencing market size by Type and application, with consumption value and growth rate by Type, application, from 2020 to 2031.
Chapter 6, 7, 8, 9, and 10, to break the Prenatal Second-Generation DNA Sequencing market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Prenatal Second-Generation DNA Sequencing market forecast, by regions, type and sales channel, with consumption value, from 2026 to 2031.
Chapter 11, Prenatal Second-Generation DNA Sequencing market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prenatal Second-Generation DNA Sequencing.
Chapter 13, to describe Prenatal Second-Generation DNA Sequencing research findings and conclusion.
Sample Report Request Prenatal Second-Generation DNA Sequencing @:
https://www.globalinforesearch.com/reports/2637650/prenatal-second-generation-dna-sequencing
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Prenatal Second-Generation DNA Sequencing by Type
1.3.1 Overview: Global Prenatal Second-Generation DNA Sequencing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Prenatal Second-Generation DNA Sequencing Consumption Value Market Share by Type in 2024
1.3.3 Genome Sequencing
1.3.4 Targeted Sequencing
1.4 Global Prenatal Second-Generation DNA Sequencing Market by Application
1.4.1 Overview: Global Prenatal Second-Generation DNA Sequencing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 High-Risk Pregnant Women Screening
1.4.3 Twin Pregnancy
1.4.4 Assisted Reproductive Technology Pregnancy
1.4.5 Low-Risk Pregnant Women Screening
1.4.6 Others
1.5 Global Prenatal Second-Generation DNA Sequencing Market Size & Forecast
1.6 Global Prenatal Second-Generation DNA Sequencing Market Size and Forecast by Region
1.6.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Prenatal Second-Generation DNA Sequencing Market Size by Region, (2020-2031)
1.6.3 North America Prenatal Second-Generation DNA Sequencing Market Size and Prospect (2020-2031)
1.6.4 Europe Prenatal Second-Generation DNA Sequencing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size and Prospect (2020-2031)
1.6.6 South America Prenatal Second-Generation DNA Sequencing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Prenatal Second-Generation DNA Sequencing Product and Solutions
2.1.4 Roche Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Roche Recent Developments and Future Plans
2.2 Natera
2.2.1 Natera Details
2.2.2 Natera Major Business
2.2.3 Natera Prenatal Second-Generation DNA Sequencing Product and Solutions
2.2.4 Natera Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Natera Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Prenatal Second-Generation DNA Sequencing Product and Solutions
2.3.4 Illumina Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Quest Diagnostics
2.4.1 Quest Diagnostics Details
2.4.2 Quest Diagnostics Major Business
2.4.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product and Solutions
2.4.4 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Quest Diagnostics Recent Developments and Future Plans
2.5 Ambry Genetics
2.5.1 Ambry Genetics Details
2.5.2 Ambry Genetics Major Business
2.5.3 Ambry Genetics Prenatal Second-Generation DNA Sequencing Product and Solutions
2.5.4 Ambry Genetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Ambry Genetics Recent Developments and Future Plans
2.6 PerkinEImer
2.6.1 PerkinEImer Details
2.6.2 PerkinEImer Major Business
2.6.3 PerkinEImer Prenatal Second-Generation DNA Sequencing Product and Solutions
2.6.4 PerkinEImer Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 PerkinEImer Recent Developments and Future Plans
2.7 Invitae
2.7.1 Invitae Details
2.7.2 Invitae Major Business
2.7.3 Invitae Prenatal Second-Generation DNA Sequencing Product and Solutions
2.7.4 Invitae Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Invitae Recent Developments and Future Plans
2.8 Neogenomics
2.8.1 Neogenomics Details
2.8.2 Neogenomics Major Business
2.8.3 Neogenomics Prenatal Second-Generation DNA Sequencing Product and Solutions
2.8.4 Neogenomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Neogenomics Recent Developments and Future Plans
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies Prenatal Second-Generation DNA Sequencing Product and Solutions
2.9.4 Agilent Technologies Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Agilent Technologies Recent Developments and Future Plans
2.10 Sema4
2.10.1 Sema4 Details
2.10.2 Sema4 Major Business
2.10.3 Sema4 Prenatal Second-Generation DNA Sequencing Product and Solutions
2.10.4 Sema4 Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Sema4 Recent Developments and Future Plans
2.11 Thermo Fisher Scientific
2.11.1 Thermo Fisher Scientific Details
2.11.2 Thermo Fisher Scientific Major Business
2.11.3 Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Product and Solutions
2.11.4 Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.12 Fulgent Genetics
2.12.1 Fulgent Genetics Details
2.12.2 Fulgent Genetics Major Business
2.12.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product and Solutions
2.12.4 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Fulgent Genetics Recent Developments and Future Plans
2.13 Genomics England
2.13.1 Genomics England Details
2.13.2 Genomics England Major Business
2.13.3 Genomics England Prenatal Second-Generation DNA Sequencing Product and Solutions
2.13.4 Genomics England Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Genomics England Recent Developments and Future Plans
2.14 BGI Genomics
2.14.1 BGI Genomics Details
2.14.2 BGI Genomics Major Business
2.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Product and Solutions
2.14.4 BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 BGI Genomics Recent Developments and Future Plans
2.15 Berry Genomics
2.15.1 Berry Genomics Details
2.15.2 Berry Genomics Major Business
2.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Product and Solutions
2.15.4 Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Berry Genomics Recent Developments and Future Plans
2.16 DAAN Gene
2.16.1 DAAN Gene Details
2.16.2 DAAN Gene Major Business
2.16.3 DAAN Gene Prenatal Second-Generation DNA Sequencing Product and Solutions
2.16.4 DAAN Gene Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 DAAN Gene Recent Developments and Future Plans
2.17 CapitalBio
2.17.1 CapitalBio Details
2.17.2 CapitalBio Major Business
2.17.3 CapitalBio Prenatal Second-Generation DNA Sequencing Product and Solutions
2.17.4 CapitalBio Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 CapitalBio Recent Developments and Future Plans
2.18 Annoroad
2.18.1 Annoroad Details
2.18.2 Annoroad Major Business
2.18.3 Annoroad Prenatal Second-Generation DNA Sequencing Product and Solutions
2.18.4 Annoroad Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Annoroad Recent Developments and Future Plans
2.19 MGI Tech
2.19.1 MGI Tech Details
2.19.2 MGI Tech Major Business
2.19.3 MGI Tech Prenatal Second-Generation DNA Sequencing Product and Solutions
2.19.4 MGI Tech Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 MGI Tech Recent Developments and Future Plans
2.20 FANdi Biotechnology
2.20.1 FANdi Biotechnology Details
2.20.2 FANdi Biotechnology Major Business
2.20.3 FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Product and Solutions
2.20.4 FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 FANdi Biotechnology Recent Developments and Future Plans
2.21 BioMiao Biotechnology
2.21.1 BioMiao Biotechnology Details
2.21.2 BioMiao Biotechnology Major Business
2.21.3 BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Product and Solutions
2.21.4 BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 BioMiao Biotechnology Recent Developments and Future Plans
2.22 JBP Medical
2.22.1 JBP Medical Details
2.22.2 JBP Medical Major Business
2.22.3 JBP Medical Prenatal Second-Generation DNA Sequencing Product and Solutions
2.22.4 JBP Medical Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 JBP Medical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prenatal Second-Generation DNA Sequencing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Prenatal Second-Generation DNA Sequencing by Company Revenue
3.2.2 Top 3 Prenatal Second-Generation DNA Sequencing Players Market Share in 2024
3.2.3 Top 6 Prenatal Second-Generation DNA Sequencing Players Market Share in 2024
3.3 Prenatal Second-Generation DNA Sequencing Market: Overall Company Footprint Analysis
3.3.1 Prenatal Second-Generation DNA Sequencing Market: Region Footprint
3.3.2 Prenatal Second-Generation DNA Sequencing Market: Company Product Type Footprint
3.3.3 Prenatal Second-Generation DNA Sequencing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Prenatal Second-Generation DNA Sequencing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Prenatal Second-Generation DNA Sequencing Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Prenatal Second-Generation DNA Sequencing Consumption Value Market Share by Application (2020-2025)
5.2 Global Prenatal Second-Generation DNA Sequencing Market Forecast by Application (2026-2031)
6 North America
6.1 North America Prenatal Second-Generation DNA Sequencing Consumption Value by Type (2020-2031)
6.2 North America Prenatal Second-Generation DNA Sequencing Market Size by Application (2020-2031)
6.3 North America Prenatal Second-Generation DNA Sequencing Market Size by Country
6.3.1 North America Prenatal Second-Generation DNA Sequencing Consumption Value by Country (2020-2031)
6.3.2 United States Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
6.3.3 Canada Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
6.3.4 Mexico Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Prenatal Second-Generation DNA Sequencing Consumption Value by Type (2020-2031)
7.2 Europe Prenatal Second-Generation DNA Sequencing Consumption Value by Application (2020-2031)
7.3 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country
7.3.1 Europe Prenatal Second-Generation DNA Sequencing Consumption Value by Country (2020-2031)
7.3.2 Germany Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
7.3.3 France Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
7.3.5 Russia Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
7.3.6 Italy Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Prenatal Second-Generation DNA Sequencing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Prenatal Second-Generation DNA Sequencing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region
8.3.1 Asia-Pacific Prenatal Second-Generation DNA Sequencing Consumption Value by Region (2020-2031)
8.3.2 China Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
8.3.3 Japan Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
8.3.4 South Korea Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
8.3.5 India Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
8.3.7 Australia Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
9 South America
9.1 South America Prenatal Second-Generation DNA Sequencing Consumption Value by Type (2020-2031)
9.2 South America Prenatal Second-Generation DNA Sequencing Consumption Value by Application (2020-2031)
9.3 South America Prenatal Second-Generation DNA Sequencing Market Size by Country
9.3.1 South America Prenatal Second-Generation DNA Sequencing Consumption Value by Country (2020-2031)
9.3.2 Brazil Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
9.3.3 Argentina Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Prenatal Second-Generation DNA Sequencing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Prenatal Second-Generation DNA Sequencing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country
10.3.1 Middle East & Africa Prenatal Second-Generation DNA Sequencing Consumption Value by Country (2020-2031)
10.3.2 Turkey Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
10.3.4 UAE Prenatal Second-Generation DNA Sequencing Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Prenatal Second-Generation DNA Sequencing Market Drivers
11.2 Prenatal Second-Generation DNA Sequencing Market Restraints
11.3 Prenatal Second-Generation DNA Sequencing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Prenatal Second-Generation DNA Sequencing Industry Chain
12.2 Prenatal Second-Generation DNA Sequencing Upstream Analysis
12.3 Prenatal Second-Generation DNA Sequencing Midstream Analysis
12.4 Prenatal Second-Generation DNA Sequencing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Contact Us
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
